Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Market Cap	3.42B -1.2%
Revenue (ttm)	2.11B -1.7%
Net Income	204.95M +0.4%
EPS	2.03 +0.4%
Shares Out	100.99M
PE Ratio	16.73
Forward PE	n/a
Dividend	1.60 (4.72%)
Ex-Dividend Date	Jul 3, 2025

Volume	54,804
Average Volume	88,518
Open	34.45
Previous Close	33.50
Day's Range	33.45 - 34.45
52-Week Range	33.20 - 40.70
Beta	0.15
RSI	31.67
Earnings Date	May 12, 2026

About Nang Kuang Pharmaceutical

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1963
• Employees: 552
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1752

Financial Performance

In 2025, Nang Kuang Pharmaceutical's revenue was 2.16 billion, a decrease of -1.71% compared to the previous year's 2.20 billion. Earnings were 244.41 million, an increase of 0.41%.